Elixir Pharmaceuticals logo
Healthcare & Life Sciences

Elixir Pharmaceuticals

Elixir Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.

series-c-plus
series-c-plus
Stage
2
Investors

About Elixir Pharmaceuticals

Elixir Pharmaceuticals is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Elixir Pharmaceuticals develops immunology-based therapeutic treatments focused on inflammatory diseases.

Explore Elixir Pharmaceuticals's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States